| 000 | 00928nam a22002897a 4500 | ||
|---|---|---|---|
| 008 | 200527b xxu||||| |||| 00| 0 eng d | ||
| 040 | _cVAD | ||
| 041 | _aNederlands | ||
| 100 |
_aVan Havere, Tina _eed. |
||
| 245 | _aUnderstanding New Psychoactive Substance (NPS) use in Belgium from a health perspective NPS-Care : conclusie en aanbevelingen [PDF] | ||
| 260 |
_aBrussels _bBELSPO _c2020 |
||
| 300 | _a43 p. | ||
| 650 | _adrugs | ||
| 650 | _aNPS | ||
| 650 | _aonderzoeksrapporten | ||
| 650 | _aproductinformatie | ||
| 650 | _aepidemiologie | ||
| 650 | _aBelgië | ||
| 650 | _aenquête | ||
| 700 | _aVander Laenen, Freya | ||
| 700 | _aColman, Charlotte | ||
| 700 | _aBlanckaert, Peter | ||
| 700 | _aGremeaux, Lies | ||
| 700 | _aSimonis, Sarah | ||
| 700 | _aVan Dijck, Anton | ||
| 856 | _uhttp://www.google.com/search?q=Understanding-New-Psychoactive-Substance-NPS-use-in-Belgium conclusies-en-aanbevelingen | ||
| 999 |
_c21044 _d21044 |
||